As per the current market research conducted by the CMI Team, the global Single Cell Multiomics Market size is expected to record a CAGR of 19.58% from 2024 to 2033. In 2024, the market size is projected to reach a valuation of USD 5.10 Billion. By 2033, the valuation is anticipated to reach USD 18.90 Billion.
Single Cell Multiomics Market: Growth Factors and Dynamics
The single cell multiomics market presents significant growth opportunities due to several factors:
- Increasing Demand for Advanced Research Solutions: They also identified a growing demand for accurate and technically efficient multiomics methods for single cell analysis by researchers and research institutions. The trends contributing to the growth and development of advanced multimodality technologies include a comprehensive data analysis integration, the steady performance of the technologies, and better research result outcomes.
- Rise in Biomedical Research and Precision Medicine: Biomedical and precision medicine warrants sophisticated single-cell multiomics solutions. This must also be associated with the increasing focus on biomedical research.
- Technological Advancements: Developments made to the single cell multiomics technologies have included more effective and efficient sequencing, bioinformatics and data integration systems that improve the usability of single cell multiomics systems, which attract research intensities and biotech companies.
- Expansion of Genomics and Proteomics Research: The need for single cell multiomics solutions results from the current global development of genomics and proteomics. Scientists look for simple and effective infrastructures to handle data intensive biological information in a highly interconnected research milieu.
- Growth in Regulatory Requirements: As the multiplicity of data protection regulatory, privacy and ethical standards continually expands to regulate the use and management of single-cell data, the demand for single-cell multi-omics solutions advances, too. Organisations are expected to have high requirements to guarantee data accuracy and credibility of the research.
- Increase in Remote Research and Collaboration: There are also new opportunities for remote research and distributed collaboration in the single-cell multiomics market. This shift results in a need to address complex multiomics requirements for secure sharing and remote data analysis.
- Urbanization and Industrial Growth: High growth rates of urbanization and industrialization, especially in developing countries, encourage demand for complex single-cell multiomics solutions. These regions are experiencing an uplift in using sophisticated multiomics solutions to enhance their growing research frameworks.
- Increasing Investments in Biotechnology: The market for single cell multiomics solutions is increasing thanks to the increasing interest in biotechnology by governments and companies across the globe. This economic factor contributes to such a market expansion and the creation of a new field of multi-omics technologies.
Report Scope
Feature of the Report | Details |
Market Size in 2024 | USD 5.10 Billion |
Projected Market Size in 2033 | USD 18.90 Billion |
Market Size in 2023 | USD 3.78 Billion |
CAGR Growth Rate | 19.58% CAGR |
Base Year | 2023 |
Forecast Period | 2024-2033 |
Key Segment | By Technology, Application, End User and Region |
Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
Buying Options | Request tailored purchasing options to fulfil your research requirements. |
Single Cell Multiomics Market: New Product Launch
- In July 2024, the Max Delbrück Center and Bruker announced a strategic partnership to build a first-of-its-kind innovation hub for systems medicine. The new center will focus on developing and applying mass spectrometry based single-cell and multi-omics technologies. The Max Delbrück Center and Bruker have launched a strategic collaboration that aims to capitalize on the expertise of both partners to accelerate innovations in systems medicine.
- In February 2024, Scale Biosciences announced its development of a new two plate workflow to dramatically scale its technology and a first set of partners to improve ease of use and enable the deployment of their portfolio across new omics applications. The new platform, announced at the 2024 Advances in Genome Biology and Technology (AGBT) general meeting, allows researchers to prepare sequencing-ready single-cell libraries of up to 2 million cells in an experiment and reduces the plates needed from three to two. This technology will form the basis for future ScaleBio innovation and product development.
- In January 2024, BD (Becton, Dickinson, and Company), a medical technology company, announced a collaboration agreement with Hamilton, a global manufacturer of laboratory automation technology, to develop automated applications together with robotics-compatible reagent kits to enable greater standardization and reduced human error when conducting large-scale single-cell multi-omics experiments. As a result of the collaboration, BD aims to deliver a suite of BD Rhapsody Single-Cell Analysis Library Preparation Reagent Kits that can be performed on the Hamilton Micro lab NGS STAR robotic liquid-handling platform.
List of the prominent players in the Single Cell Multiomics Market:
- 10x Genomics
- Illumina
- Bio-Rad Laboratories
- Fluidigm
- Becton, Dickinson and Company (BD)
- Takara Bio
- Mission Bio
- Celsee
- NanoString Technologies
- Parse Biosciences
- Scipio Bioscience
- Oxford Nanopore Technologies
- QIAGEN
- Agilent Technologies
- PerkinElmer
- Others
The Single Cell Multiomics Market is segmented as follows:
By Technology
- Single-cell RNA Sequencing (scRNA-seq)
- Single-cell DNA Sequencing (scDNA-seq)
- Single-cell Proteomics
- Single-cell Epigenomics
- Single-cell Metabolomics
- Single-cell Transcriptomics
- Other
By Application
- Cancer Research
- Immunology
- Neurology
- Stem Cell Research
- Developmental Biology
- Drug Discovery and Development
- Other
By End User
- Academic and Research Institutions
- Biotechnology and Pharmaceutical Companies
- Clinical Research Organizations
- Hospitals and Diagnostic Laboratories
- Other
Regional Coverage:
North America
- U.S.
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- France
- U.K.
- Russia
- Italy
- Spain
- Netherlands
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Taiwan
- Rest of Asia Pacific
The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of the Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America